ADMA Biologics, Inc. (ADMA) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-02-25 18:27:52 ET
ADMA Biologics, Inc. (ADMA) Q4 2025 Earnings Call February 25, 2026 4:30 PM EST
Company Participants
Adam Grossman - Co-Founder, President, CEO & Director
Brad Tade - CFO & Treasurer
Terry Kohler
...
Read the full article on Seeking Alpha
For further details see:
ADMA Biologics, Inc. (ADMA) Q4 2025 Earnings Call Transcript
ADMA Biologics Inc
NASDAQ: ADMA
ADMA Trading
-2.79% G/L:
$14.995 Last:
1,023,703 Volume:
$15.12 Open:
ADMA Latest News
March 02, 2026 07:00:00 am
ADMA Biologics Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase Initiative
February 25, 2026 04:05:00 pm
ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
February 18, 2026 07:00:00 am
ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
ADMA Stock Data
$3,926,963,123
229,191,848
0.3%
148
N/A
Biotechnology & Life Sciences
Healthcare
US
Ramsey
